AI-generated summary
This review describes how low reactive level laser therapy is thought to act at the cellular level and how it has been applied to mesenchymal stem and stromal cell therapies. The authors also report their own recent findings that this light treatment enhanced differentiation of these cells into osteoblasts. The abstract does not provide sample sizes or details of the supporting experiments.
- Limits stated in the abstract
- The abstract does not report sample sizes, study designs, or the specific wavelengths and doses used in the authors' own research.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Low reactive level laser therapy (LLLT) is mainly focused on the activation of intracellular or extracellular chromophore and the initiation of cellular signaling by using low power lasers. Over the past forty years, it was realized that the laser therapy had the potential to improve wound healing and reduce pain and inflammation. In recent years, the term LLLT has become widely recognized in the field of regenerative medicine. In this review, we will describe the mechanisms of action of LLLT at a cellular level and introduce the application to mesenchymal stem cells and mesenchymal stromal cells (MSCs) therapies. Finally, our recent research results that LLLT enhanced the MSCs differentiation to osteoblast will also be described.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wound healing, Inflammation, Chromophore. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.